L
LENSAR, Inc. (LNSR)
NCM – Real Time Price. Currency in USD
6.29
+0.26 (4.31%)
At close: Aug 12, 2026, 4:00 PM EDT
6.29
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
6.29
+0.26 (4.31%)
At close: Aug 12, 2026, 4:00 PM EDT
6.29
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:10 PM EDT
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
| Name | Position |
|---|---|
| Mr. Alan B. Connaughton | Chief Operating Officer |
| Mr. Michael A. Rossi | Interim CFO & Principal Financial Officer and Secretary |
| Mr. Nicholas T. Curtis | President, CEO & Director |
| Ms. Kendra W. Wong | Principal Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-08-10 | 8-K | lnsr-20260804.htm |
| 2026-06-23 | ARS | lnsr-ars-2025annualrepor.pdf |
| 2026-06-02 | S-8 | lnsr-20260602.htm |
| 2026-05-29 | 8-K | lnsr-20260525.htm |
| 2026-05-08 | 8-K | lnsr-20260508.htm |
| 2026-05-08 | 10-Q | lnsr-20260331.htm |
| 2026-04-30 | 10-K/A | lnsr-20251231.htm |
| 2026-04-15 | 8-K | lnsr-20260410.htm |
| 2026-03-31 | 8-K | lnsr-20260331.htm |
| 2026-03-31 | 10-K | lnsr-20251231.htm |